Rep. Anna Eshoo (D-CA) (Graeme Sloan/AP Images)
June 23, 2022 12:17 PM EDTUpdated 12:58 PM
FDA+
Law

Fight over where to house ARPA-H still brews with House bil­l's pas­sage

Zachary Brennan

Senior Editor

The Biden ad­min­is­tra­tion isn’t back­ing down from its de­sire to keep a new drug ac­cel­er­a­tor, known as ARPA-H, in­side the Na­tion­al In­sti­tutes of Health. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

FDA gives Ab­b­Vie ac­cel­er­at­ed ap­proval for an­ti­body-drug con­ju­gate in lung can­cer

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

RFK Jr. de­fends HHS staff cuts, re­or­ga­ni­za­tion plans in House, Sen­ate hear­ings

RFK Jr. says his opin­ions of vac­cines are ‘ir­rel­e­vant.’ For­mer FDA chief Califf dis­agrees

No­vo turns to Septer­na for oral obe­si­ty med­i­cines in deal worth up to $2.2B

A service from the Financial Times